Cancer screening blood tests

Cancer screening from the comfort of your home

Early detection of cancer is vital for successful treatment and cure. Failure of timely detection invariably leads to intensive and toxic treatments, high treatment costs and treatment failure.

Introducing: EasyCheck360®

A revolutionary multi-cancer early-stage detection test based on a simple blood test.

Convenient blood test for asymptomatic individuals in the age of 30 years & above
Covers 30+ types of cancers including Breast, Ovary, Lung, Colon, Pancreas, Liver & more

Starting at ₹6000

Non-Invasive
& Radiation Free

At-home blood
Sample Collection

>99%
Accuracy

- EasyCheck360
  
  Multi-cancer screening test
  Detects 30 types of cancers
  
  Including Lung, Kidney, Gallbladder, Ovaries, Prostate and more
  
  At ₹14000 only
- EasyCheck - Diabetes
  
  Cancer screening test for people with diabetes. Detects 6 types of cancers
  
  Including Liver, Pancreaticobiliary, Kidney, Bladder, Rectum and Colon Cancers
  
  At ₹9000 only
- EasyCheck - Femmesafe
  
  Cancer screening test for women
  Detects 4 types of cancers
  
  Including Breast, Ovarian, Endometrial and Cervical Cancers
  
  At ₹9000 only
- EasyCheck - Prostate
  
  Cancer screening test for men
  Detects prostate cancer
  
  Includes detection of
  Prostate Cancer
  
  At ₹6000 only

EasyCheck360® is the outcome of intensive research efforts of the last several years by internationally recognized scientists and doctors. It has been rigorously validated for its analytical and clinical performance characteristics. Datar Cancer Genetics is a global oncology research and applications company specializing in non-invasive technologies for improved detection, treatment, and management of cancer. The company's state-of-the-art facility is NABL, ISO, CAP, and CLIA accredited. The Company serves cancer patients and suspected cases in the UK, European Union, United States, GCC, and India. The company is pursuing large clinical studies in Europe and in the United States to cover multiple cancers where there is a potential of cure with early detection. The company also proposes to have multiple test centers globally.

Need help?

Get a call back from our health advisor

Frequently Asked Questions

It helps to detect the existence of cancer.

This test is not intended to be and should not be considered as a replacement for any Standard of Care screening tests.

Within the limits of error, a 'negative' result is a reasonable indication of undetectable cancer of the type covered by the test. For other cancers not covered by the test, no inference should be drawn from a 'negative' result.

As EasyCheck360 is a non-invasive blood test, there is no disadvantage in frequent testing. However, we advise that EasyCheck360® should be performed every 12 months in case of negative results.

No, such individuals should seek expert medical advice without delay.

The test indicates the location for the select types of cancers with high accuracy, and in others, the tissue of origin can be identified with reasonable accuracy. In all cases of 'positive' results, the report should be interpreted by your physician who can guide you on the further course of action.